By Donald Zuhn --
Applied Nanoscience Inc. announced today (July 6, 2007) that it has entered into a settlement agreement with NanoScale Coroporation. The agreement ends the lawsuit NanoScale filed against Applied Nanoscience, Emergency Filtration Products, Inc., Applied Nanoscience President Thomas K. Allen, and Emergency Filtration Products President and CEO Douglas K. Beplate, on July 27, 2006 in the U.S. District Court for the District of Kansas.
In addition to claims of false advertising, copyright infringement, misappropriation of trade secrets, breach of contract, breach of fiduciary duties, tortious interference with business expectancy, and unfair competition, NanoScale also asserted a number of its patents against the Defendants, including U.S. Patent Nos. 6,057,488; 6,087,294; 6,093,236; 6,417,423; and 6,653,519. The asserted patents are directed, in part, to nanocrystalline metal oxides, organometallic compounds, and haolgenated derivatives thereof, as well as to methods of using such compounds for destroying biological agents such as toxins and bacteria.
As recently as last November, NanoScale issued a statement saying that it believed the Defendants' responses to its complaint were "without merit" and that it would "continue to vigorously pursue the allegations" in its complaint. The terms of the settlement were not disclosed.
Comments